Kidney cancer clinical trials consortium

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH2120025
Recipient
Awarding agency
Obligated
$1,300,292

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Nashville, TN 37232, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Kidney cancer clinical trials consortium DE-obligate funds to close award per section 711 of the national defense authorization act (NDAA) 2019, the US army… -$105,812
Amendment 1. Extends the period of performance by one year at an additional cost to the government of $368,104 per the recipient S email 16 june 2022. Technical and… $368,104
Amendment Exercises the option.2. Provides funding for the exercised option year in the amount of $519,000 via PR 0011637967-0003.3. Updates items a.5.II, a.7, a.10.VI,… $519,000
Amendment This administrative modification establishes the line item for the option year. Division I items a.4, a.5.II, and a.6. Are updated. $0
Original award $519,000

Quick answers

Who received award W81XWH2120025?

W81XWH2120025 was awarded to Vanderbilt University Medical Center by Defense Health Agency (Department of Defense) on September 15, 2021.

How much is award W81XWH2120025 worth?

$1,300,292 has been obligated on W81XWH2120025.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login